Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.

Oncotarget · 2016 · PMC5342446 · PMID 27494886

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The increase was highly significant in stimulated T lymphocytes, MOLT-4 and JURKAT cells, whereas did not occur in unstimulated T lymphocytes.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.